Nature Communications (Mar 2021)

SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19

  • Jun Wu,
  • Boyun Liang,
  • Cunrong Chen,
  • Hua Wang,
  • Yaohui Fang,
  • Shu Shen,
  • Xiaoli Yang,
  • Baoju Wang,
  • Liangkai Chen,
  • Qi Chen,
  • Yang Wu,
  • Jia Liu,
  • Xuecheng Yang,
  • Wei Li,
  • Bin Zhu,
  • Wenqing Zhou,
  • Huan Wang,
  • Sumeng Li,
  • Sihong Lu,
  • Di Liu,
  • Huadong Li,
  • Adalbert Krawczyk,
  • Mengji Lu,
  • Dongliang Yang,
  • Fei Deng,
  • Ulf Dittmer,
  • Mirko Trilling,
  • Xin Zheng

DOI
https://doi.org/10.1038/s41467-021-22034-1
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 9

Abstract

Read online

A better understanding of longitudinal changes in antibody responses in COVID-19 patients is needed. Here the authors analyze anti-spike and anti-nucleocapsid antibody responses to Sars-CoV-2 over a course of 6 months in a large cohort of patients with COVID-19, showing that IgM is mostly not detectable after 3 months, whereas IgG responses contract, yet remain at high levels at 6 months.